References
- Kim CJ. Effects of drug solubility, drug loading, and polymer molecular weight on drug release from Polyox tablets. Drug Dev Ind Pharm 1998;24:645–51
- Kim CJ. Drug release from compressed hydrophilic POLYOX-WSR tablets. J Pharm Sci 1995;84:303–6
- Wu N, Wang LS, Tan DC, et al. Mathematical modeling and in vitro study of controlled drug release via a highly swellable and dissoluble polymer matrix: polyethylene oxide with high molecular weights. J Contr Rel 2005;102:569–81
- Maggi L, Segale L, Torre ML, et al. Dissolution behaviour of hydrophilic matrix tablets containing two different polyethylene oxides (PEOs) for the controlled release of a water-soluble drug. Dimensionality study. Biomaterials 2002;23:1113–19
- Molina I, Li S, Martinez MB, Vert M. Protein release from physically crosslinked hydrogels of the PLA/PEO/PLA triblock copolymer-type. Biomaterials 2001;22:363–9
- Shah AP, Bhandary SR. POLYOX (Polyethylene Oxide) – applications in pharma industry. Pharmainfo.net; 2010. Available from: http://www.pharmainfo.net/reviews/polyox-polyethylene-oxide-applications-pharma-industry
- Siepmann J, Peppas NA. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv Drug Deliv Rev 2001;48:139–57
- Wu C. Simulated glass transition of poly(ethylene oxide) bulk and film: a comparative study. J Phys Chem B 2011;115:11044–52
- Palmer D, Levina M, Nokhodchi A, et al. The influence of sodium carboxymethylcellulose on drug release from polyethylene oxide extended release matrices. AAPS PharmSciTech 2011;12:862–71
- Shah R, Patel S, Patel H, et al. Formulation development of Carvedilol compression coated tablet. Pharm Dev Technol 2011;18:906--15
- Crowley MM, Zhang F, Koleng JJ, Mcginity JW. Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion. Biomaterials 2002;23:4241–8
- Pinto JF, Wunder KF, Okoloekwe A. Evaluation of the potential use of poly(ethylene oxide) as tablet- and extrudate-forming material. AAPS J 2004;6:17–26
- Leskinen JT, Hakulinen MA, Kuosmanen M, et al. Monitoring of swelling of hydrophilic polymer matrix tablets by ultrasound techniques. Int J Pharm 2011;404:142–7
- Li H, Hardy RJ, Gu X. Effect of drug solubility on polymer hydration and drug dissolution from polyethylene oxide (PEO) matrix tablets. AAPS PharmSciTech 2008;9:437–43
- Li H, Gu X. Correlation between drug dissolution and polymer hydration: a study using texture analysis. Int J Pharm 2007;342:18–25
- Korner A, Piculell L, Iselau F, et al. Influence of different polymer types on the overall release mechanism in hydrophilic matrix tablets. Molecules 2009;14:2699–716
- Shin S, Choi du H, Truong NK, et al. Time-oriented experimental design method to optimize hydrophilic matrix formulations with gelation kinetics and drug release profiles. Int J Pharm 2011;407:53–62
- Harland RS, Gazzaniga A, Sangalli ME, et al. Drug/polymer matrix swelling and dissolution. Pharm Res 1988;5:488–94
- Colombo P, Bettini R, Massimo G, et al. Drug diffusion front movement is important in drug release control from swellable matrix tablets. J Pharm Sci 1995;84:991–7
- Korner A, Larsson A, Andersson A, Piculell L. Swelling and polymer erosion for poly(ethylene oxide) tablets of different molecular weights polydispersities. J Pharm Sci 2010;99:1225–38
- Apicella A, Cappello B, Del nobile MA, et al. Poly(ethylene oxide) (peo) and different molecular weight peo blends monolithic devices for drug release. Biomaterials 1993;14:83–90
- Miro A, Quaglia F, Giannini L, et al. Drug/cyclodextrin solid systems in the design of hydrophilic matrices: a strategy to modulate drug delivery rate. Curr Drug Deliv 2006;3:373–8
- Cappello B, De Rosa G, Giannini L, et al. Cyclodextrin-containing poly(ethyleneoxide) tablets for the delivery of poorly soluble drugs: potential as buccal delivery system. Int J Pharm 2006;319:63–70
- Tajiri T, Morita S, Sakamoto R, et al. Release mechanisms of acetaminophen from polyethylene oxide/polyethylene glycol matrix tablets utilizing magnetic resonance imaging. Int J Pharm 2010;395:147–53
- Hong SI, Oh SY. Dissolution kinetics and physical characterization of three-layered tablet with poly(ethylene oxide) core matrix capped by Carbopol. Int J Pharm 2008;356:121–9
- Kim CJ. Release kinetics of coated, donut-shaped tablets for water soluble drugs. Eur J Pharm Sci 1999;7:237–42
- Korner A, Larsson A, Piculell L, Wittgren B. Molecular information on the dissolution of polydisperse polymers: mixtures of long and short poly(ethylene oxide). J Phys Chem B 2005;109:11530–7
- Petrovic J, Jockovic J, Ibric S, Duric Z. Modelling of diclofenac sodium diffusion from swellable and water-soluble polyethylene oxide matrices. J Pharm Pharmacol 2009;61:1449–56
- Park JS, Shim JY, Nguyen KV, et al. A pharma-robust design method to investigate the effect of PEG and PEO on matrix tablets. Int J Pharm 2010;393:79–87
- Sako K, Nakashima H, Sawada T, Fukui M. Relationship between gelation rate of controlled-release acetaminophen tablets containing polyethylene oxide and colonic drug release in dogs. Pharm Res 1996;13:594–8
- Bagchi S, Li W, Plakogiannis F. Optimization and prediction of drug release from matrix tablets using response surface methodology and near infrared chemical imaging. Pharm Dev Technol 2012;17:398–406
- Quinten T, De beer T, Almeida A, et al. Development and evaluation of injection-molded sustained-release tablets containing ethylcellulose and polyethylene oxide. Drug Dev Ind Pharm 2011;37:149–59
- Cha KH, Park J, Cho W, et al. Design of pH-independent extended release matrix tablets of minocycline hydrochloride for the treatment of dementia. Arch Pharm Res 2009;32:1593–8
- Di Colo G, Falchi S, Zambito Y. In vitro evaluation of a system for pH-controlled peroral delivery of metformin. J Control Release 2002;80:119–28
- Peppas NA, Sahlin JJ. Hydrogels as mucoadhesive and bioadhesive materials: a review. Biomaterials 1996;17:1553–61
- Forstner JF, Jabbal I, Forstner GG. Goblet cell mucin of rat small intestine. Chemical and physical characterization. Can J Biochem 1973;51:1154–66
- Tiwari D, Goldman D, Sause R, Madan PL. Evaluation of polyoxyethylene homopolymers for buccal bioadhesive drug delivery device formulations. AAPS PharmSci 1999;1:E13
- Bottenberg P, Cleymaet R, De muynck C, et al. Development and testing of bioadhesive, fluoride-containing slow-release tablets for oral use. J Pharm Pharmacol 1991;43:457–64
- Sadeghi AM, Avadi MR, Ejtemaimehr S, et al. Development of a gas empowered drug delivery system for peptide delivery in the small intestine. J Contr Rel 2009;134:11–17
- El-Samaligy MS, Yahia SA, Basalious EB. Formulation and evaluation of diclofenac sodium buccoadhesive discs. Int J Pharm 2004;286:27–39
- Miro A, Rondinone A, Nappi A, et al. Modulation of release rate and barrier transport of Diclofenac incorporated in hydrophilic matrices: role of cyclodextrins and implications in oral drug delivery. Eur J Pharm Biopharm 2009;72:76–82
- Streubel A, Siepmann J, Bodmeier R. Gastroretentive drug delivery systems. Expert Opin Drug Deliv 2006;3:217–33
- Talukder R, Fassihi R. Gastroretentive delivery systems: a mini review. Drug Dev Ind Pharm 2004;30:1019–28
- Rouge N, Buri P, Doelker E. Drug absorption sites in the gastrointestinal tract and dosage forms for site-specific delivery. Int J Pharm 1996;136:117–39
- Streubel A, Siepmann J, Bodmeier R. Floating microparticles based on low density foam powder. Int J Pharm 2002;241:279–92
- Meka L, Kesavan B, Chinnala KM, et al. Preparation of a matrix type multiple-unit gastro retentive floating drug delivery system for captopril based on gas formation technique: in vitro evaluation. AAPS PharmSciTech 2008;9:612–19
- Cooreman MP, Krausgrill P, Hengels KJ. Local gastric and serum amoxicillin concentrations after different oral application forms. Antimicrob Agents Chemother 1993;37:1506–9
- Liu Q, Fassihi R. Zero-order delivery of a highly soluble, low dose drug alfuzosin hydrochloride via gastro-retentive system. Int J Pharm 2008;348:27–34
- Needleman IG, Martin GP, Smales FC. Characterisation of bioadhesives for periodontal and oral mucosal drug delivery. J Clin Periodontol 1998;25:74–82
- Kapil R, Kapoor DN, Dhawan S. Flow, compressive, and bioadhesive properties of various blends of poly(ethylene oxide). Drug Dev Ind Pharm 2010;36:45–55
- Vaghani SS, Patel SG, Jivani RR, et al. Design and optimization of a stomach-specific drug delivery system of repaglinide: application of simplex lattice design. Pharm Dev Technol 2012;17:55–65
- Verma RK, Mishra B, Garg S. Osmotically controlled oral drug delivery. Drug Dev Ind Pharm 2000;26:695–708
- Park SJ, Kim KS, Kim SH. Effect of poly(ethylene oxide) on the release behaviors of poly(epsilon-caprolactone) microcapsules containing erythromycin. Colloids Surf B Biointerfaces 2005;43:238–44
- Rose S, Nelson JF. A continuous long-term injector. Aust J Exp Biol Med Sci 1955;33:415–19
- Theeuwes F. Elementary osmotic pump. J Pharm Sci 1975;64:1987–91
- Swanson DR, Barclay BL, Wong PSL, Theeuwes F. Nifedipine gastrointestinal therapeutic system. Am J Med 1987;83:3–9
- Liu L, Khang G, Rhee JM, Lee HB. Monolithic osmotic tablet system for nifedipine delivery. J Contr Rel 2000a;67:309–22
- Turner S, Federici C, Hite M, Fassihi R. Formulation development and human in vitro--in vivo correlation for a novel, monolithic controlled-release matrix system of high load and highly water-soluble drug niacin. Drug Dev Ind Pharm 2004;30:797–807
- Liu L, Ku J, Khang G, et al. Nifedipine controlled delivery by sandwiched osmotic tablet system. J Contr Rel 2000b;68:145–56
- Liu L, Khang G, Rhee JM, Lee H B. Sandwiched osmotic tablet core for nifedipine controlled delivery. Biomed Mater Eng 1999;9:297–310
- Kumaravelrajan R, Narayanan N, Suba V, Bhaskar K. Simultaneous delivery of Nifedipine and Metoprolol tartarate using sandwiched osmotic pump tablet system. Int J Pharm 2010;399:60–70
- Wang X, Nie SF, Li W, et al. Studies on bi-layer osmotic pump tablets of water-insoluble allopurinol with large dose: in vitro and in vivo. Drug Dev Ind Pharm 2007;33:1024–9
- Wang C, Chen F, Heng PW, et al. A novel time-controlled release system based on drug--resin complexes and elementary osmotic pump. Chem Pharm Bull (Tokyo) 2008;56:457–63
- Budman SH, Grimes Serrano JM, Butler SF. Can abuse deterrent formulations make a difference? Expectation and speculation. Harm Reduct 2009;6:8
- Letter TM. In brief: immediate-release oxycodone (Oxecta) for pain. The Medical Letter. Available from: http://secure.medicalletter.org/w1385d [last accessed 28 April 2013]
- Depomed. About GRALISE. Depomed. Available from: http://www.gralise.com/patient/about [last accessed 28 April 2013]
- Santarus. glumetza® [Online]. RxList. Available from: http://www.rxlist.com/glumetza-drug.htm [last accessed 28 April 2013]
- Merck. Janumet® XR. Rxlist. Available from: http://www.rxlist.com/janumet-xr-drug.htm [last accessed 28 April 2013]
- Glaxosmithkline. DynaCirc CR®. RxList. Available from: http://www.rxlist.com/dynacirc-cr-drug.htm [last accessed 28 April 2013]
- Pfizer. Cardura® XL. RxList. Available from: http://www.rxlist.com/cardura-xl-drug.htm [last accessed 28 April 2013]
- Pfizer. glucotrol xl ®. RxList. Available from: http://www.rxlist.com/glucotrol-xl-drug.htm [last accessed 28 April 2013]
- Pfizer. procardia xl®. RxList. Available from: http://www.rxlist.com/procardia-xl-drug.htm [last accessed 28 April 2013]
- Pfizer. covera-hs®. RxList. Available from: http://www.rxlist.com/covera-hs-drug.htm [last accessed 28 April 2013]
- Purdue. OxyContin®. RxList. Available from: http://www.rxlist.com/oxycontin-drug.htm [last accessed 27 April 2013]
- Elzweig M. OPANA: a brief history. NewYorkPress. Available from: http://nypress.com/opana-a-brief-history/ [last accessed April 2013]
- Jassen. NUCYNTA®ER. RxList. [last accessed 28 April 2013]
- Varma M, Singla AK, Dhawan S. Release of diltiazem hydrochloride from hydrophilic matrices of polyethylene oxide and carbopol. Drug Dev Ind Pharm 2004;30:545–53